A novel stem cell platform has allowed researchers from the Medical University of South Carolina (MUSC) to pinpoint a biological pathway that could be targeted by drugs to combat fat accumulation in patients suffering from metabolic dysfunction-associated steatotic liver disease (MASLD). This discovery, led by Stephen Duncan, Ph.D., SmartState Endowed Chair in Regenerative Medicine at MUSC, and Caren Doueiry, an M.D., Ph.D. candidate working in Duncan’s lab, offers a promising step forward in addressing a disease that affects a significant portion of the population. Their findings have been pu…